Apaf1 and the apoptotic machinery

被引:102
作者
Cecconi, F [1 ]
机构
[1] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany
关键词
Bax; BclX(L); Boo; caspases; CARD; cytochrome c;
D O I
10.1038/sj.cdd.4400602
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular characterization of the Caenorhabditis elegans cell death genes has been crucial in revealing some of the biochemical mechanisms underlying apoptosis in all animals. Four C. elegans genes, egl-1, ced-9, ced-4 and ced-3 are required for all somatic programmed cell death to occur. This genetic network is highly conserved during evolution. The pro-death gene egl-1 and the anti-death gene ced-9 have structural and functional similarities to the vertebrate Bcl2 gene family. The killer gene ced-3 encodes a cystein-aspartate protease (caspase), which is the archetype of a family of conserved proteins known as effecters of apoptosis in mammals. Zou and collaborators(1) reported the biochemical identification of an apoptotic protease activating factor (Apaf4), a human homolog of C, elegans CED-4, providing important dues to how CED-4 and its potential relatives could work. A number of proteins have been shown to interact with Apaf1 or to be determinant for its activity as an apoptotic adapter. The aim of this review is to provide an overview of the recent progress made in the field of developmental apoptosis by means of the murine Apaf1 targeted mutations. The central role of Apaf1 in the cell death machinery (apoptosome) and its involvement in different apoptotic pathways will also be discussed.
引用
收藏
页码:1087 / 1098
页数:12
相关论文
共 94 条
  • [81] T-CELL APOPTOSIS DETECTED IN-SITU DURING POSITIVE AND NEGATIVE SELECTION IN THE THYMUS
    SURH, CD
    SPRENT, J
    [J]. NATURE, 1994, 372 (6501) : 100 - 103
  • [82] ICE-related proteases in apoptosis
    Takahashi, A
    Earnshaw, WC
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) : 50 - 55
  • [83] Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
    Varfolomeev, EE
    Schuchmann, M
    Luria, V
    Chiannilkulchai, N
    Beckmann, JS
    Mett, IL
    Rebrikov, D
    Brodianski, VM
    Kemper, OC
    Kollet, O
    Lapidot, T
    Soffer, D
    Sobe, T
    Avraham, KB
    Goncharov, T
    Holtmann, H
    Lonai, P
    Wallach, D
    [J]. IMMUNITY, 1998, 9 (02) : 267 - 276
  • [84] PREVENTION OF PROGRAMMED CELL-DEATH IN CAENORHABDITIS-ELEGANS BY HUMAN BCL-2
    VAUX, DL
    WEISSMAN, IL
    KIM, SK
    [J]. SCIENCE, 1992, 258 (5090) : 1955 - 1957
  • [85] BCL-2 PREVENTS DEATH OF FACTOR-DEPRIVED CELLS BUT FAILS TO PREVENT APOPTOSIS IN TARGETS OF CELL-MEDIATED KILLING
    VAUX, DL
    AGUILA, HL
    WEISSMAN, IL
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (07) : 821 - 824
  • [86] BID: A novel BH3 domain-only death agonist
    Wang, K
    Yin, XM
    Chao, DT
    Milliman, CL
    Korsmeyer, SJ
    [J]. GENES & DEVELOPMENT, 1996, 10 (22) : 2859 - 2869
  • [87] Essential contribution of caspase 3 CPP32 to apoptosis and its associated nuclear changes
    Woo, M
    Hakem, R
    Soengas, MS
    Duncan, GS
    Shahinian, A
    Kägi, D
    Hakem, A
    McCurrach, M
    Khoo, W
    Kaufman, SA
    Senaldi, G
    Howard, T
    Lowe, SW
    Mak, TW
    [J]. GENES & DEVELOPMENT, 1998, 12 (06) : 806 - 819
  • [89] Apaf1 is required for mitochondrial pathways of apoptosis and brain development
    Yoshida, H
    Kong, YY
    Yoshida, R
    Elia, AJ
    Hakem, A
    Hakem, R
    Penninger, JM
    Mak, TW
    [J]. CELL, 1998, 94 (06) : 739 - 750
  • [90] YUAN JY, 1992, DEVELOPMENT, V116, P309